Irene Griswold-Prenner

Person

Brisbane, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Use of perlecan domain V in treating amyloidogenic disease
- Patent number 9,358,273
- Issue date Jun 7, 2016
- The Texas A&M University System
- Gregory J. Bix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of inhibiting amyloid toxicity
- Patent number 7,901,683
- Issue date Mar 8, 2011
- Elan Pharmaceuticals, Inc.
- Irene Griswold-Prenner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating cognitive impairment
- Patent number 7,829,087
- Issue date Nov 9, 2010
- Elan Pharmaceuticals, Inc.
- Sarah Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Signaling intermediates in an in vitro model of Alzheimer's disease
- Patent number 7,674,597
- Issue date Mar 9, 2010
- Elan Pharmaceuticals, Inc.
- Nikolay Malinin
- G01 - MEASURING TESTING
Information Patent Grant
Alpha-synuclein kinase
- Patent number 7,553,639
- Issue date Jun 30, 2009
- Elan Pharma International Limited
- Tami J. Chilcote
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
USE OF PERLECAN DOMAIN V IN TREATING AMYLOIDOGENIC DISEASE
- Publication number 20130036481
- Publication date Feb 7, 2013
- THE TEXAS A&M UNIVERSITY SYSTEM
- Gregory J. Bix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALPHA-SYNUCLEIN KINASE
- Publication number 20110207796
- Publication date Aug 25, 2011
- ELAN PHARMA INTERNATIONAL LIMITED
- JOHN P. ANDERSON
- G01 - MEASURING TESTING
Information Patent Application
SIGNALING INTERMEDIATES IN AN IN VITRO MODEL OF ALZHEIMER'S DISEASE
- Publication number 20100303824
- Publication date Dec 2, 2010
- Elan Pharmaceuticals, Inc.
- NIKOLAY MALININ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALPHA-SYNUCLEIN KINASE
- Publication number 20100143946
- Publication date Jun 10, 2010
- Elan Pharma International Limited
- JOHN P. ANDERSON
- G01 - MEASURING TESTING
Information Patent Application
METHODS FOR USING MODULATORS OF PROLINE-RICH TYROSINE KINASE 2
- Publication number 20090227656
- Publication date Sep 10, 2009
- Elan Pharmaceuticals, Inc.
- Irene Griswold-Prenner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF INHIBITING AMYLOID TOXICITY
- Publication number 20090220505
- Publication date Sep 3, 2009
- IRENE GRISWOLD-PRENNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Alpha-Synuclein Kinase
- Publication number 20080300206
- Publication date Dec 4, 2008
- Elan Pharmaceuticals, Inc.
- John P. Anderson
- G01 - MEASURING TESTING
Information Patent Application
Methods of suppressing LTP inhibition
- Publication number 20080193444
- Publication date Aug 14, 2008
- Sarah Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALPHA-SYNUCLEIN KINASE
- Publication number 20080160011
- Publication date Jul 3, 2008
- Elan Pharmaceuticals, Inc.
- Tami J. Chilcote
- G01 - MEASURING TESTING
Information Patent Application
Signaling intermediates in an in vitro model of Alzheimer's disease
- Publication number 20060159674
- Publication date Jul 20, 2006
- Nikolay Malinin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods for using modulators of proline-rich tyrosine kinase 2
- Publication number 20050059621
- Publication date Mar 17, 2005
- Irene Griswold-Prenner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Irene Griswold-Prenner

Person

Patents Grantslast 30 patents

Use of perlecan domain V in treating amyloidogenic disease

Methods of inhibiting amyloid toxicity

Methods of treating cognitive impairment

Signaling intermediates in an in vitro model of Alzheimer's disease

Alpha-synuclein kinase

Patents Applicationslast 30 patents

USE OF PERLECAN DOMAIN V IN TREATING AMYLOIDOGENIC DISEASE

ALPHA-SYNUCLEIN KINASE

SIGNALING INTERMEDIATES IN AN IN VITRO MODEL OF ALZHEIMER'S DISEASE

ALPHA-SYNUCLEIN KINASE

METHODS FOR USING MODULATORS OF PROLINE-RICH TYROSINE KINASE 2

METHODS OF INHIBITING AMYLOID TOXICITY

Alpha-Synuclein Kinase

Methods of suppressing LTP inhibition

ALPHA-SYNUCLEIN KINASE

Signaling intermediates in an in vitro model of Alzheimer's disease

Methods for using modulators of proline-rich tyrosine kinase 2